Advanced search
Publication Cover
Cancer Investigation Volume 22, 2004 - Issue 2
Submit an article Journal homepage
50
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Comparative Study of the Immunohistochemical Phenotype in Breast Cancer and Its Lymph Node Metastatic Location

Juan R. De la Haba-Rodríguez Medical Oncology Department, Reina Sofía Hospital, Córdoba, Spain; Servicio de Oncología Médica del Hospital Provincial, Complejo Universitario Reina Sofía, Avda. Menéndez Pidal s.n., Córdoba, 14004, Spain
, M.D. , Ph.D.,
Manuel Ruiz Borrego Pathological Anatomy Department, Virgen del Rocío Hospital, Seville, Spain
, M.D. , Ph.D.,
Auxiliadora Gómez España Medical Oncology Department, Reina Sofía Hospital, Córdoba, Spain
, M.D. , Ph.D.,
Carlos Villar Pastor Medical Oncology Department, Virgen de Rocío Hospital, Sevilla, Spain
, M.D.,
Miguel A. Japón Pathological Anatomy Department, Reina Sofía Hospital, Córdoba, Spain
, M.D.,
Paulino Travado Pathological Anatomy Department, Reina Sofía Hospital, Córdoba, Spain
, M.D.,
José Andrés Moreno Nogueira Pathological Anatomy Department, Virgen del Rocío Hospital, Seville, Spain
, M.D.,
Fernando López Rubio Medical Oncology Department, Virgen de Rocío Hospital, Sevilla, Spain
, M.D. &
Enrique Aranda Aguilar Medical Oncology Department, Reina Sofía Hospital, Córdoba, Spain
, M.D. show all
Pages 219-224 | Published online: 24 Aug 2009

References

  • Manni A., Arafah B., Pearson O. H. Estrogen and progesterone receptor in the prediction of the response of the breast cancer to endocrine therapy. Cancer 1980; 46: 424
  • Chen L., Kurisu W., Ljung B., Goldman E., Moore E., Smith H. Heterogeneity for allelic loss in human breast cancer. J. Natl. Cancer Inst. 1992; 84: 506–510, [PUBMED], [INFOTRIEVE]
  • McGuire W. L. Breast cancer prognostic factors: evaluation guidelines. J. Natl. Cancer Inst. 1991; 83: 154–155, [PUBMED], [INFOTRIEVE]
  • Gaparini G., Pozza F., Harris A. L. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J. Natl. Cancer Inst. 1993; 85: 1206–1219
  • Levini M. N., Browman G. P., Gent M., Roberts R., Goodyear M. When is a prognosis factor useful? A guide for perplexed. J. Clin. Oncol. 1991; 9: 448–456
  • Hilsenbeck S., Ravdin P., de Moor C., Chammess G., Osborne C., Clark G. M. Time dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res. Treat. 1998; 52: 227–231, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Fisher B., Redmond C., Fisher E. R., Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of the differentiation as indicator of prognosis in node negative breast cancer patients: findings National Surgical Adjuvant Breast and Bowel Project protocol B-06. J. Clin. Oncol. 1988; 6: 1076–1081, [PUBMED], [INFOTRIEVE]
  • Kukasjarvi T., Kononen J., Helin H., Holli K., Isola J. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J. Clin. Oncol. 1996; 14: 2584–2587
  • Bronw R. W., Allred D. C., Clark G. M. Prognostic value of Ki-67 compared to S-phase fraction in axillary node negative breast cancer. Clin. Cancer Res. 1996; 2: 585–605, [CSA]
  • Dettmar P., Harbeck N., Thomssen C., Panche L., Ziffer P., Fizi K., Janicke F., Nathrath W., Schmitt M., Graeff H., Hofler H. Prognosis impact of proliferation associated factors MIB1 (Ki-67) and S-phase in node negative breast cancer. Br. J. Cancer 1997; 75: 1525–1531, [PUBMED], [INFOTRIEVE]
  • Gerdes J., Schwab U., Lemke H., et al. Production of mouse monoclonal antibodie reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer. 1983; 31: 13–19, [PUBMED], [INFOTRIEVE]
  • Barnes D. M., Dublín E. A., Fisher C. J., Levison D. A., Millis R. R. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?. Human Pathol. 1993; 24: 469–473, [CROSSREF]
  • Briffod M., Hacène K., Le Doussal V. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases. Mod. Path. 2000; 13(8)841–850, [CSA], [CROSSREF]
  • Barnes D. M., Lammie G. A., Millis R. R., Gullick W. L., Allen D. S., Altman D. G. An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma B. J. Cancer 1988; 58: 448–452
  • Tubiana-Hulin M., Hacen K., Martín P. M., Spyratos F. Prognostic factor clustering in breast cancer: biology or chronology?. Eur. J. Cancer 1995; 31a: 283–284
  • Jatoi I., Hilsenbeck S. G., Clark G. M., Osborne C. K. Significance of axillary lymph node metastasis in primary breast cancer. J. Clin. Oncol. 1999; 17: 2334–2340, [PUBMED], [INFOTRIEVE]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.